These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 26526356)
1. A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer. Liu D; Deng Q; Sun L; Wang T; Yang Z; Chen H; Guo L; Liu Y; Ma Y; Guo N; Shi M BMC Cancer; 2015 Nov; 15():832. PubMed ID: 26526356 [TBL] [Abstract][Full Text] [Related]
2. The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells. Shi M; Liu D; Duan H; Qian L; Wang L; Niu L; Zhang H; Yong Z; Gong Z; Song L; Yu M; Hu M; Xia Q; Shen B; Guo N Breast Cancer Res Treat; 2011 Jan; 125(2):351-62. PubMed ID: 20237834 [TBL] [Abstract][Full Text] [Related]
3. β2-AR signaling controls trastuzumab resistance-dependent pathway. Liu D; Yang Z; Wang T; Yang Z; Chen H; Hu Y; Hu C; Guo L; Deng Q; Liu Y; Yu M; Shi M; Du N; Guo N Oncogene; 2016 Jan; 35(1):47-58. PubMed ID: 25798840 [TBL] [Abstract][Full Text] [Related]
4. Decrease of let-7f in low-dose metronomic Paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer. Tao WY; Liang XS; Liu Y; Wang CY; Pang D Int J Biol Sci; 2015; 11(1):48-58. PubMed ID: 25552929 [TBL] [Abstract][Full Text] [Related]
5. Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors. Wielgos ME; Rajbhandari R; Cooper TS; Wei S; Nozell S; Yang ES Mol Cancer Res; 2017 Mar; 15(3):340-347. PubMed ID: 28031413 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer. Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA let-7 establishes expression of beta2-adrenergic receptors and dynamically down-regulates agonist-promoted down-regulation. Wang WC; Juan AH; Panebra A; Liggett SB Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6246-51. PubMed ID: 21447718 [TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1. Shibahara Y; Miki Y; Onodera Y; Hata S; Chan MS; Yiu CC; Loo TY; Nakamura Y; Akahira J; Ishida T; Abe K; Hirakawa H; Chow LW; Suzuki T; Ouchi N; Sasano H J Pathol; 2012 Jul; 227(3):357-66. PubMed ID: 22407818 [TBL] [Abstract][Full Text] [Related]
9. β2-AR-induced Her2 transactivation mediated by Erbin confers protection from apoptosis in cardiomyocytes. Shi M; Zhao M; Hu M; Liu D; Cao H; Qian L; Yang Z; Hu Y; Yu M; Yang S; Ma Y; Guo N Int J Cardiol; 2013 Aug; 167(4):1570-7. PubMed ID: 22564389 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer. Lyu S; Yu Q; Ying G; Wang S; Wang Y; Zhang J; Niu Y Int J Oncol; 2014 Jan; 44(1):229-37. PubMed ID: 24172884 [TBL] [Abstract][Full Text] [Related]
11. β2-AR activation promotes cleavage and nuclear translocation of Her2 and metastatic potential of cancer cells. Liu D; Zha L; Liu Y; Zhao X; Xu X; Liu S; Ma W; Zheng J; Shi M Cancer Sci; 2020 Dec; 111(12):4417-4428. PubMed ID: 33016509 [TBL] [Abstract][Full Text] [Related]
12. Catecholamine-Induced β2-adrenergic receptor activation mediates desensitization of gastric cancer cells to trastuzumab by upregulating MUC4 expression. Shi M; Yang Z; Hu M; Liu D; Hu Y; Qian L; Zhang W; Chen H; Guo L; Yu M; Song L; Ma Y; Guo N J Immunol; 2013 Jun; 190(11):5600-8. PubMed ID: 23630346 [TBL] [Abstract][Full Text] [Related]
13. A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer. Gargiulo L; May M; Rivero EM; Copsel S; Lamb C; Lydon J; Davio C; Lanari C; Lüthy IA; Bruzzone A J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):43-57. PubMed ID: 28074314 [TBL] [Abstract][Full Text] [Related]
14. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol. Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863 [TBL] [Abstract][Full Text] [Related]
15. Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers. Kollara A; Kahn HJ; Marks A; Brown TJ Breast Cancer Res Treat; 2001 Jun; 67(3):245-53. PubMed ID: 11561770 [TBL] [Abstract][Full Text] [Related]
16. A CREB-mediated increase in miRNA let-7f during prolonged β-agonist exposure: a novel mechanism of β Kim D; Cho S; Woo JA; Liggett SB FASEB J; 2018 Jul; 32(7):3680-3688. PubMed ID: 29455573 [TBL] [Abstract][Full Text] [Related]
17. β2-microglobulin has a different regulatory molecular mechanism between ER Chai D; Li K; Du H; Yang S; Yang R; Xu Y; Lian X BMC Cancer; 2019 Mar; 19(1):223. PubMed ID: 30866857 [TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139 [TBL] [Abstract][Full Text] [Related]
19. Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling. Brennan K; McSherry EA; Hudson L; Kay EW; Hill AD; Young LS; Hopkins AM Oncogene; 2013 May; 32(22):2799-804. PubMed ID: 22751120 [TBL] [Abstract][Full Text] [Related]
20. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1. Lattrich C; Juhasz-Boess I; Ortmann O; Treeck O Oncol Rep; 2008 Mar; 19(3):811-7. PubMed ID: 18288420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]